Physician

Alexander Engelman, M.D.

According to 2025 Medicare claims, Alexander Engelman, M.D. (NPI: 1679863658) practices radiation oncology in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is FLORIDA UROLOGY PARTNERS, LLP (NPI: 1447401955; TIN: 261300103) and primary practice location at 33609-9998. Engelman is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Engelman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 574 traditional Medicare patients, billed 14,260 HCPCS/CPT codes, and received $2,206,429 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,399 prescription claims across 514 beneficiaries totaling $15,083,545 in drug costs, led by Erleada (Apalutamide). DME data shows 12 claims. Open Payments data shows 150 records totaling $25,155. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $105,888 and ending at $2,206,429. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,496 to $15,083,545. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	38	589	$105,888
2018	284	14,185	$2,346,209
2019	319	15,278	$2,487,693
2020	362	11,827	$1,978,112
2021	488	12,409	$2,586,397
2022	507	11,219	$2,498,807
2023	552	9,768	$2,277,658
2024	574	14,260	$2,206,429

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	51	$5,496
2016	N/R	N/R	N/R
2017	27	41	$2,837
2018	166	501	$22,883
2019	247	708	$113,202
2020	291	899	$761,211
2021	402	1,651	$4,890,268
2022	536	2,556	$11,231,982
2023	569	2,562	$13,147,457
2024	514	2,399	$15,083,545

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$603

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	158	158	$165
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	357	612	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	150	159	$58
77300	Calculation of radiation therapy dose	136	472	$49
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	462	799	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	660	20,220	$9,623,883
Nubeqa	Darolutamide	234	7,020	$3,103,599
Orgovyx	Relugolix	420	12,750	$1,109,222
Xtandi	Enzalutamide	65	2,070	$933,470
Lupron Depot	Leuprolide Acetate	29	3,000	$197,733

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	12	$603

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	146	$17,177	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$7,978	Sumitomo Pharma America, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander Engelman, M.D.?

Tedicare shows public-source Medicare data for Alexander Engelman, M.D. (NPI 1679863658), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Engelman, M.D. have ACO affiliation data?

Alexander Engelman, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Alexander Engelman, M.D.?

Alexander Engelman, M.D. is linked to FLORIDA UROLOGY PARTNERS, LLP (billing NPI 1447401955) in the available physician profile data.

Does Alexander Engelman, M.D. have Open Payments data?

Alexander Engelman, M.D. has 150 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.